title: [Embolization therapy of cavernous hemangiomas].
abstract: Hemangiomas are the most frequent tumors found in newborns, but mostly regress by the age of 7. Spontaneous progression and such complications as hemorrhage, disseminated intravascular coagulation (Kasabach-Merritt syndrome), threatened cardiovascular decompensation, and threatened interference with vital functions are rare and must be treated. Embolization therapy is a new therapeutic approach: vascular malformations and hemangiomas with pronounced arteriovenous shunts are treated by selective arterial embolization of the most peripheral branches of the supplying blood vessels. In contrast, lesions with a steady, slow blood perfusion can be treated by direct embolization of the cavernous system; further thrombosis and organization of the thrombus may lead to a permanent and complete occlusion of the hemangioma. If permanent occlusion cannot be achieved, temporary or partial thrombosis may allow curative plastic or reconstructive surgery, which would otherwise be impossible.
authors: I. Universitäts-Hautklinik Wien.
authors: K
authors: K
authors: Rappersberger
authors: P
authors: P
authors: Samec
authors: E
authors: E
authors: Diem
mesh_terms: D002015:Bucrylate; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic / Q000379:methods*; D005153:Facial Neoplasms / Q000601:surgery / Q000628:therapy*; D006392:Hemangioma, Cavernous / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007223:Infant; D008048:Lip Neoplasms / Q000601:surgery / Q000628:therapy*; D008297:Male
chemical_list: D002015:Bucrylate
vernacular_title: Die Embolisations-Therapie kavernöser Hämangiome.